Galena Biopharma To Present At BioX: Noble Financial Capital Markets' Life Sciences Exposition

LAKE OSWEGO, Oregon, Sept. 18, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will present a corporate update at BioX: Noble Financial Capital Markets' Life Sciences Exposition. The presentation will take place on September 24, 2012 at 8:00 AM EDT at the University of Connecticut, Stamford Campus.

The presentation will be webcast and available on September 27, 2012 on the Investors section of the Company's website at www.galenabiopharma.com .

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com .

The Galena Biopharma, Inc. logo is available at  http://www.globenewswire.com/newsroom/prs/?pkgid=10647
CONTACT: Madeline Hatton         Toll free: +1 (855) 855-GALE (4253), ext. 109         info@galenabiopharma.com                  Remy Bernarda         IR Sense, LLC         +1 (503) 400-6995         remy@irsense.com

Galena Biopharma, Inc.

If you liked this article you might like

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

How to Dig Deep for Value in These Exuberant Markets

How to Dig Deep for Value in These Exuberant Markets

Value Investors Have to Go Deeper

Value Investors Have to Go Deeper

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments

How to Expertly Trade Monday's Most Active Stocks -- AMD, Newell Brands, Hasbro and More